Download PDF - Evonik Industries
Download PDF - Evonik Industries
Download PDF - Evonik Industries
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Evonik</strong> Chemicals –<br />
Benchmark setting innovation process<br />
Strong Intellectual Property portfolio<br />
• >300 new patent applications every year and<br />
>20,000 patents in total<br />
• ~ one third of sales generated from patent-protected<br />
products/technologies<br />
Customer benefit determines R&D intensity<br />
• Measurable customer benefit as decisive factor (e.g.<br />
customer bonding, supply chain integration)<br />
• Overall R&D expenses almost 3% of sales<br />
1 Euro R&D expenditure = 1.5 Euros new annual sales<br />
5 October 2009 | Investors Conference Call<br />
350<br />
136<br />
329<br />
313<br />
228 224<br />
347 340 353<br />
319<br />
298 289<br />
2003 2004 2005 2006 2007 2008<br />
# of 1st patent applications thereof covering China<br />
application<br />
development<br />
15%<br />
New patents 2003 - 2008<br />
process improvement<br />
30%<br />
*as of 10 September 2009<br />
Strong commitment to R&D …<br />
€300m plus annual research and<br />
development expenditure<br />
(~3% R&D to sales ratio)<br />
85% of R&D in Business Units<br />
*<br />
15% explorative<br />
research<br />
new product<br />
development<br />
40%<br />
Page | 7
Change language